Loading stock data…
$1.72+0.05 (+2.99%)
BioHarvest Sciences Inc.
BioHarvest Sciences Inc. Common Stock in the Consumer Defensive sector is trading at $1.72 with a market capitalization of $41M. Wall Street consensus targets $10.50 (4 analysts), implying a +510.5% move over the next 12 months. The stock is currently near its 52-week low of $1.37, remaining 48.3% below its 200-day moving average. On fundamentals, Piotroski 6/9 shows mixed financial quality, Altman Z in the distress zone. The Whystock Score of 40/100 suggests a balanced risk-reward profile.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $8.84M↑ | $8.51M↓ | $9.07M | $9.07M↑ | $8.52M |
| Gross Profit | $5.08M↑ | $5.04M↓ | $5.22M↓ | $5.57M↑ | $5.09M |
| Operating Income | -$2.51M↓ | -$1.83M↓ | -$1.12M↓ | -$920,000↑ | -$1.81M |
| Net Income | -$3.71M↓ | -$2.64M↓ | -$2.20M↑ | -$2.51M↑ | -$4.08M |
BioHarvest Sciences Inc. operates as a biotechnology company in Israel and the United States. It operates through two segments: Products and CDMO Services. The company develops botanical synthesis platform technology to produce plant cells with highe...